Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Moderna, Inc.(MRNA) | 9,666,038 | 4,632,149 | -5,033,889 | $1.03B | $550.07M | 65.22% | -$479.95M |
| Sana Biotechnology, Inc.(SANA) | 25,001,856 | 25,001,856 | 0 | $250.02M | $136.51M | 16.19% | -$113.51M |
| Foghorn Therapeutics Inc.(FHTX) | 12,674,120 | 12,674,120 | 0 | $85.04M | $72.88M | 8.64% | -$12.17M |
| Omega Therapeutics Inc | 29,225,579 | 29,225,579 | 0 | $106.67M | $60.50M | 7.17% | -$46.18M |
| Seres Therapeutics, Inc.(MCRB) | 23,117,045 | 23,117,045 | 0 | $17.89M | $16.73M | 1.98% | -$1.16M |
| Syros Pharmaceuticals Inc | 1,293,849 | 1,293,849 | 0 | $6.92M | $6.68M | 0.79% | -$245.8K |
| Denali Therapeutics Inc.(DNLI) | 1,364,516 | 0 | -1,364,516 | $28.00M | $0 | — | -$28.00M |